SEATTLE, Feb. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. , a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 11th Annual BIO CEO & Investor Conference in New York City at 10:30 a.m. Eastern Time on Monday, February 9, 2009.
A live and archived webcast of Dr. Kirkman’s presentation can be accessed at www.oncothyreon.com under the “News & Events” section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
CONTACT: Investor and Media Relations Contact: Julie Rathbun, Rathbun
Communications, (206) 769-9219, ir@oncothyreon.com
